期刊文献+

HPLC法测定非那西丁和对乙酰氨基酚的血浓度 被引量:3

下载PDF
导出
摘要 利用探针药物检测CYP450同工酶活性是临床药理学和生理、生化实验等研究的重要手段之一。非那西丁(phenacetin)是研究P4501A2(CYP1A2)酶活性的特异性底物,非那西丁试验通过口服或注射非那西丁后,同时测定血中非那西丁及其代谢产物对乙酰氨基酚的药物浓度,以反应CYP1A2在体内的活性。本实验建立的方法简便、快捷,灵敏度、准确度高,为非那西丁试验研究肝脏CYP1A2在体内的药物代谢活性提供了一种准确、快捷的方式。
出处 《北方药学》 2012年第1期47-47,共1页 Journal of North Pharmacy
  • 相关文献

参考文献1

二级参考文献29

  • 1朱大岭,贺锡雯.CYP1A1基因型与吸烟及肺癌的关系[J].国外医学(卫生学分册),1996,23(2):96-98. 被引量:6
  • 2许振华,周宏灏.细胞色素氧化酶P4501A2与药物代谢[J].中国临床药理学杂志,1996,12(2):115-121. 被引量:22
  • 3Beresford AP, Ellis WJ, Ayrton J, et al. Cytochrome P4501A(CYP1A) induction in rat and man by the benzodioxino derivative, fluparoxan[J]. Xenobiotica, 1997,27(2) : 159.
  • 4Kaminsky LS, Zhang ZY. Human P450 metabolism of warfarin.[J]. Pharmacol Ther, 1997,73 ( 1 ) : 67.
  • 5Pollenz RS. The ary-hydrocarbon receptor nuclear translocator protein is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2, 3,7, 8-tetrachlordibenzo-p-dioxin [ J ]. Mol Pharmacol, 1996,49(3) :391.
  • 6Xu L, Li AP, Kaminski DL, et al. 2,3,7,8-Tetrachlordibenzo-pdioxin inducti-on of cytochrome P4501A in cultured rat and human hepatocytes[J]. Chem Bid Interact, 2000,124(3) : 173.
  • 7Moorthy B. Persistent expression of 3-methylcholanthrene-in-ducible cytochromes P4501A in rat hepatic and extrahepatic tissues [J] . J Pharmacol Exp Ther,2000,294(1):313.
  • 8Degawa M, Nakayama M, Konno Y, et al. 2-Methoxy-4-nitroaniline and its isomers induce cytochrome P4501A(CYP1A) enzymes with different seleetivities in the rat liver[J]. Biochim Biophys Acta, 1998,1379(3) :391.
  • 9Klenam MI, Overvik E, Poellinger L, et al. Induction of cytochrome P4501A isozymes by heterocyclic amines and other food-derived compounds[J]. Princess Takamatsu Symp, 1995,23 : 163.
  • 10Iba MM, Scholl H, Fung J, et al. Induction of pulmonary CYP1A1 by nicotine[J]. Xenobiotica, 1998,28(9) :827.

共引文献17

同被引文献23

  • 1Chae YH,Yun CH,Guengerich FP,et al. Roles of human hepatic andPulmonary cytochrome P450 enzymes in the metabolism of the environmental carcinogen 6-Nitro- chrysene[J]. Cancer Res i 1993,53 (9) 2028 2034.
  • 2Smith G,Stubbins MJ, Harries I.W, et al. Molecular ge- netics of the human cytochrome P450 monooxygenase su- per familyJ. Xenobiotica,1998,28(12) :1129-1165.
  • 3Rifkind AB. CYP1A in TCDD toxicity and in physiology- With particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates [J]. Drug Metabol Revi,2006,38(1/2):291-335.
  • 4Schwarz M, Appel KE. Carcinogenic risks of dioxin: mechanisticconsiderationsFJ. Regul Toxicol Pharmacol, 2005,43(1) : 19-34.
  • 5Tanaka E, Kurata N, Yasuhara H. How useful is the cocktail approachr for evaluating human hepatic drug me- tabolizing capacity using cytochrome P450 phenotyping probes in vivo[J]. J Clin Pharm Ther, 2003,28 (3) : 157- 165.
  • 6Dahl ML. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics Useful aid to prescribing [J]. Clinl Pharmacokinet,2002,41(7) :453-470.
  • 7Huang W,Qu ZQ,Li XD,et al. The effect of transcathe- ter arterial chemoembolization on CYPIA2 activity in pa tients with hepatocellular carcinoma[J]. J Clin Pharm T- her,2008,33(5) :489-493.
  • 8E1 Kommos ME, Emara KM. Determination of phenyl- toloxamine salicylamide, caffeine, paracetamol, codeine and phenacetin by HPLC[J]. Talanta, 1989,36 ( 6 ) : 678- 679.
  • 9刘哲,王祥瑞.细胞色素酶P450 1A2表型分析及其应用价值[J].实用医学杂志,2008,24(5):871-872. 被引量:2
  • 10王潇,刘华,白洁.细胞色素P450调节肝脏药物代谢的途径[J].生物技术通报,2009,25(7):39-41. 被引量:8

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部